Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Lupus Nephritis
Related studies linked through entity extraction aliases.
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
- Status
- UNKNOWN
- Phase
- PHASE2
Urine Exosomes to Identify Biomarkers for LN
- Status
- UNKNOWN
- Phase
- N/A
Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
- Status
- WITHDRAWN
- Phase
- PHASE2
Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
- Status
- COMPLETED
- Phase
- NA
Daratumumab to Treat Active Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
- Status
- RECRUITING
- Phase
- PHASE3
Epigenetics in Lupus Nephritis
- Status
- UNKNOWN
- Phase
- N/A
Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis
- Status
- COMPLETED
- Phase
- N/A
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Status
- TERMINATED
- Phase
- PHASE2
Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
- Status
- UNKNOWN
- Phase
- N/A
Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis
- Status
- COMPLETED
- Phase
- N/A
Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis
- Status
- RECRUITING
- Phase
- NA
Comparison between2 Drugs in Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE4